Amedisys (NASDAQ:AMED) rose 1% in after hours trading after a divestiture agreement in its planned sale to UnitedHealth (NYSE ...

Amedisys (Nasdaq: AMED) announced on Thursday that the company has reached agreements to divest home health and hospice care centers to affiliates of the ...

In 2022, the healthcare giant recognized that home healthcare was a growing ... as well as paying a breakup fee to Option ...

Amedisys delivers first-quarter top-line growth across three of its segments, namely Home Health, Hospice and High Acuity Care. Although the revenue and EPS for Amedisys (AMED) give a sense of how ...

Amedisys (Nasdaq: AMED) exceeded Wall Street expectations in its first-quarter results for 2025. The company’s home health segment benefited from ...

AMED insiders have traded $AMED stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales. Here’s a ...

Amedisys spurned a previous $3.6 billion all-stock bid from infusion company Option Care Health UnitedHealth Group operates home health and hospice locations in 37 states under its LHC Group ...

Noah Tong UnitedHealth Group and Amedisys outlined plans to divest a significant number of home health and hospice locations ... gaps across the continuum of care as well as advance value-based ...

The home health care and hospice services provider posted revenue of $594.8 million in the period, which met Street forecasts. Amedisys shares have climbed 3% since the beginning of the year. In the ...

Advertisement Article continues below this ad The home health care and hospice services provider posted revenue of $594.8 million in the period, which met Street forecasts. Amedisys shares have ...

The home health care and hospice services provider posted revenue of $594.8 million in the period, which met Street forecasts. Amedisys shares have climbed 3% since the beginning of the year.